Physician profile
Ashok Sehgal
NPI 1083713374
$984.96
in general payments reported to CMS, 2019-2025
16 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $105 · 2021: $308 · 2022: $186 · 2023: $84.35 · 2024: $62.79 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $215.51 | 2019-2022 | |
| Alcon Vision LLC | $143.90 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $117.45 | 2019-2023 | Cequa |
| Allergan, INC. | $96.67 | 2019-2022 | |
| Astellas Pharma US INC | $62.79 | 2024 | Izervay |
| Biotissue Holdings INC. | $62.29 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $55.81 | 2021 | |
| Dompe US, INC. | $52.28 | 2025 | Oxervate |
| Abbvie INC. | $35.73 | 2022-2023 | Alphagan P, Lumigan, Vuity |
| Tarsus Pharmaceuticals, INC. | $33.79 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $24.15 | 2021 | |
| Thea Pharma INC. | $21.76 | 2025 | Iyuzeh |
| Omeros Corporation | $16.59 | 2019 | |
| Rayner Intraocular Lenses Limited | $16.46 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Ocular Therapeutix, INC. | $15.17 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $14.61 | 2023 | Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Sehgal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.